FOUR gene biomarkers may offer a highly accurate approach to identifying post-transplant acute kidney injury (AKI), according to a new study that integrated transcriptomic, single cell, animal, and human clinical data to develop and validate a diagnostic signature.
Identifying Biomarkers for Post Transplant AKI
AKI following renal transplantation remains a common and serious complication, largely driven by ischaemia reperfusion injury (IRI). Despite its clinical importance, reliable biomarkers for the early identification of post-transplant AKI remain unavailable.
To address this challenge, researchers analysed transcriptomic datasets from multiple cohorts. Using weighted gene co-expression network analysis and differential expression analysis in a discovery cohort, they identified 222 candidate genes associated with early allograft IRI. These candidates were subsequently refined within an integrated training cohort through least absolute shrinkage and selection operator regression and support vector machine recursive feature elimination.
This process identified a four gene signature consisting of SOCS3, MYC, TGIF1, and LETM2. The model demonstrated excellent diagnostic performance in the training cohort (10-fold cross-validation AUC = 0.969).
Strong Validation Across Independent Cohorts
The four gene signature maintained high discriminative accuracy when tested in independent external datasets. Validation in a large external cohort produced an area under the curve of: 0.942, supporting the robustness of the findings across diverse patient populations.
Decision curve analyses suggested that the signature could provide clinical benefit for the early identification of post-transplant AKI across a broad threshold probability range. The model also demonstrated favourable performance when compared with several established biomarkers, including neutrophil gelatinase associated lipocalin.
These findings suggest that the gene panel may help address an important unmet need in transplant medicine by improving the early detection of kidney injury following transplantation.
Biological Evidence Supports Diagnostic Potential
Further analyses examined the expression of the four genes across renal cell types and in experimental and clinical AKI samples. Single cell transcriptomic analysis revealed cell type specific expression patterns across multiple renal compartments.
Experimental validation showed that protein levels of SOCS3, MYC, TGIF1, and LETM2 were elevated in mouse kidneys 24 hours after IRI. High expression of all four proteins was also observed in human AKI biopsy samples.
In addition, serum concentrations of SOCS3 and LETM2 were elevated in patients with cardiac surgery associated AKI. However, TGIF1 and MYC did not reach statistical significance in these samples.
Conclusion
The authors concluded that this four gene signature has potential utility as an early diagnostic biomarker panel for post-transplant AKI. They noted that larger clinical studies will be required to confirm its diagnostic performance and determine its role in clinical practice.
Reference
Feng J et al. A four-gene signature for diagnosis of acute kidney injury following kidney transplantation. Ren Fail. 2026;48(1):2687235.
Featured Image: N F/peopleimages.com on Adobe Stock
- Author:
